LONDON--(BUSINESS WIRE)--Technavio has been monitoring the global head and neck cancer diagnostics market since 2015 and the market is poised to grow by USD 3.41 billion during 2020-2024 at a CAGR of almost 12% during the forecast period. Request Free Sample Pages
Read the 161-page research report with TOC on "Head and Neck Cancer Diagnostics Market Analysis Report by Geography (Asia, Europe, North America, and ROW), by Diagnostic Methods (Biopsy and blood tests, Imaging, Endoscopy, and Dental diagnostics), and Segment Forecasts, 2020-2024".
https://www.technavio.com/report/head-and-neck-cancer-diagnostics-market-industry-analysis
The increasing number of cancer-related initiatives and rising popularity of immunotherapy in head and neck cancer treatment are anticipated to boost the growth of the market.
Many private and government organizations are undertaking several initiatives to prevent and control cancer by promoting cancer awareness, cancer treatment, and early cancer diagnosis. For instance, the American Cancer Society, established in 1913, has introduced global health programs and global cancer-control initiatives to facilitate early diagnosis of cancers such as head and neck cancer to save lives and minimize suffering. This is driving the demand for head and neck cancer diagnostic equipment such as computed tomography, magnetic resonance imaging scanners, and emission tomography. Thus, the increasing number of cancer-awareness initiatives are expected to drive market growth during the forecast period.
Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.
View market snapshot before purchasing
Major Five Head and Neck Cancer Diagnostics Market Companies:
Accuray Inc.
Accuray Inc. is headquartered in the US and operates the business under the Oncology systems group segment. The company offers Radixact, which is an intensity modulated radiation therapy (IG-IMRT) system. The company also offers TomoTherapy with an integrated 3D image guidance and unique binary MLC.
Apteryx Imaging Inc.
Apteryx Imaging Inc. is headquartered in Canada and offers products through the following business units: Hardware and Software. The company offers VELscope Vx System, which is a powerful device for enhanced visualization of mucosal abnormalities.
Canon Inc.
Canon Inc. is headquartered in Japan and operates under various business segments, namely Office Business Unit, Imaging System Business Unit, Industry and Others Business Unit, and Medical System Business Unit. The company offers an MR system, Vantage Titan 1.5T.
General Electric Co.
General Electric Co. is headquartered in the US and offers products through the following business segments: Aviation, Power, Oil and gas, Healthcare, Renewable energy, Transportation, Lighting, and Capital. The company offers SIGNA Pioneer - 70cm, Discovery MR750w GEM - 70cm, SIGNA PET/MR with QuantWorks, and others.
KARL STORZ SE & Co. KG
KARL STORZ SE & Co. KG is headquartered in Germany and offers products through the following business segments: Human Medicine, Industrial, and Veterinary Medicine. The company offers C-MAC FIVE S and C-MAC S USB.
Register for a free trial today and gain instant access to 17,000+ market research reports. Technavio's SUBSCRIPTION platform
Head and Neck Cancer Diagnostics Diagnostic Methods Outlook (Revenue, USD Million, 2020-2024)
- Biopsy and blood tests
- Imaging
- Endoscopy
- Dental diagnostics
Head and Neck Cancer Diagnostics Regional Outlook (Revenue, USD Million, 2020-2024)
- Asia
- Europe
- North America
- ROW
Technavio’s sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more. Request a free sample report
Related Reports on Health Care include:
Fallopian Tube Cancer Therapeutics Market – Global Fallopian Tube Cancer Therapeutics Market by product (targeted therapy and chemotherapy) and geography (Asia, Europe, North America, and ROW).
Cancer Biologics Market – Global Cancer Biologics Market by product (monoclonal antibodies, vaccines, cell and gene therapy, and others) and geography (Asia, Europe, North America, and ROW).
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
